Recently, PTX3 was identified as a predictor of 28-day mortality of hospitalized COVID-19 patients, with increased PTX3 hypothesized to reflect the failure to regulate uncontrolled inflammation (Brunetta et al., 2021). The gene discussed is PTX3; the disease is COVID-19.